<DOC>
	<DOC>NCT00799032</DOC>
	<brief_summary>To evaluate the short-term and mid-term safety and efficacy of the Catania coronary stent for the treatment of up to two de novo lesions in native coronary arteries.</brief_summary>
	<brief_title>The ATLANTA First in Man Study of the Catania Stent</brief_title>
	<detailed_description>This is a prospective, non-randomized, first-in-man single center study. The study requires a 55 patients with documented myocardial ischemia undergoing PCI.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Lesion length ≤ 20 mm Vessel size ≥ 2.5 ≤ 3.5 mm Life expectancy &lt; 1 year Left ventricular ejection fraction (LVEF) &lt;30% Antithrombotic drug intolerance</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Coronary Stent</keyword>
</DOC>